ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Orally Disintegrating Tablet Excipient Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-2G510
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Orally Disintegrating Tablet Excipient Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Orally Disintegrating Tablet Excipient Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-2G510
Report
July 2025
Pages:149
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
DFE Pharma
Fuji Chemical Industries
Merck KGaA
Ashland Inc
Meggle Pharma
Cargill Incorporated
BASF
ROQUETTE
ABF Ingredients
Evonik
Shin-Etsu
McePharma (Vivesa holding)
Daicel Corporation
Anhui Sunhere Pharmaceutical
BASF AG
JRS Pharma

Orally Disintegrating Tablet Excipient Market Size

In 2024, the global market size of Orally Disintegrating Tablet Excipient was estimated to be worth US$ 17830 million and is forecast to reach approximately US$ 22600 million by 2031 with a CAGR of 3.5% during the forecast period 2025-2031.

Orally Disintegrating Tablet Excipient Market

Orally Disintegrating Tablet Excipient Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet Excipient.
The Orally Disintegrating Tablet Excipient market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Tablet Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Orally Disintegrating Tablet Excipient Market Report

Report Metric Details
Report Name Orally Disintegrating Tablet Excipient Market
CAGR 3.5%
Segment by Type
  • Binders
  • Glidents
  • Diluents
  • Disintegrants
  • Others
Segment by Application
  • Anti-Psychotics Drug
  • Anti-Epileptics Drug
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Orally Disintegrating Tablet Excipient in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orally Disintegrating Tablet Excipient sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the McePharma (Vivesa holding), BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical share in Orally Disintegrating Tablet Excipient Market?

Ans: McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.

What is the Orally Disintegrating Tablet Excipient Market share by region?

Ans: APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

Who are the main players in the Orally Disintegrating Tablet Excipient Market report?

Ans: The main players in the Orally Disintegrating Tablet Excipient Market are BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, McePharma (Vivesa holding), Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical

What are the Application segmentation covered in the Orally Disintegrating Tablet Excipient Market report?

Ans: The Applications covered in the Orally Disintegrating Tablet Excipient Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Others

What are the Type segmentation covered in the Orally Disintegrating Tablet Excipient Market report?

Ans: The Types covered in the Orally Disintegrating Tablet Excipient Market report are Binders, Glidents, Diluents, Disintegrants, Others

1 Study Coverage
1.1 Orally Disintegrating Tablet Excipient Product Introduction
1.2 Market by Type
1.2.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts
2.1.1 Global Orally Disintegrating Tablet Excipient Revenue 2020-2031
2.1.2 Global Orally Disintegrating Tablet Excipient Sales 2020-2031
2.2 Orally Disintegrating Tablet Excipient Market Size by Region: 2024 Versus 2031
2.3 Orally Disintegrating Tablet Excipient Sales by Region (2020-2031)
2.3.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2020-2025
2.3.2 Global Orally Disintegrating Tablet Excipient Sales Forecast by Region (2026-2031)
2.3.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2020-2031)
2.4 Orally Disintegrating Tablet Excipient Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2020-2025
2.4.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2026-2031)
2.4.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2020-2031)
3.1.1.1 Global Orally Disintegrating Tablet Excipient Sales Volume by Type (2020-2031)
3.1.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2031)
3.1.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2020-2031)
3.1.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Type (2020-2031)
3.1.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2020-2031)
3.1.3 Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2020-2031)
3.2.1.1 Global Orally Disintegrating Tablet Excipient Sales Volume by Application (2020-2031)
3.2.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2031)
3.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2020-2031)
3.2.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Application (2020-2031)
3.2.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2020-2031)
3.2.3 Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Binders of Orally Disintegrating Tablet Excipient Revenue Market Share by Application
3.3.2 Glidents of Orally Disintegrating Tablet Excipient Revenue Market Share by Application
3.3.3 Diluents of Orally Disintegrating Tablet Excipient Revenue Market Share by Application
3.3.4 Disintegrants of Orally Disintegrating Tablet Excipient Revenue Market Share by Application
3.3.5 Others of Orally Disintegrating Tablet Excipient Revenue Market Share by Application
4 Global Orally Disintegrating Tablet Excipient by Manufacturers
4.1 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Sales (2020-2025)
4.1.1 Global Orally Disintegrating Tablet Excipient Sales by Manufacturer (2020-2025)
4.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Revenue (2020-2025)
4.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturer (2020-2025)
4.2.2 Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturer (2020-2025)
4.3 Global Orally Disintegrating Tablet Excipient Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Orally Disintegrating Tablet Excipient Manufacturers Covered: Ranking by Revenue
4.4.2 Global Orally Disintegrating Tablet Excipient Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Orally Disintegrating Tablet Excipient Manufacturing Base Distribution, Product Type
4.5.1 Orally Disintegrating Tablet Excipient Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
4.5.3 Manufacturers Orally Disintegrating Tablet Excipient Product Type and Application
4.5.4 Binders Market Sales of Orally Disintegrating Tablet Excipient by Manufacturer
4.5.5 Glidents Market Sales of Orally Disintegrating Tablet Excipient by Manufacturer
4.5.6 Diluents Market Sales of Orally Disintegrating Tablet Excipient by Manufacturer
4.5.7 Disintegrants Market Sales of Orally Disintegrating Tablet Excipient by Manufacturer
4.5.8 Others Market Sales of Orally Disintegrating Tablet Excipient by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 BASF
5.1.1 BASF Company Information
5.1.2 BASF Description, Business Overview
5.1.3 BASF Orally Disintegrating Tablet Excipient Products Offered
5.1.4 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.1.5 BASF Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.1.6 BASF Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.1.7 BASF Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.1.8 BASF Recent Developments
5.2 JRS Pharma
5.2.1 JRS Pharma Company Information
5.2.2 JRS Pharma Description, Business Overview
5.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Products Offered
5.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.2.5 JRS Pharma Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.2.6 JRS Pharma Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.2.7 JRS Pharma Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.2.8 JRS Pharma Recent Developments
5.3 Roquette
5.3.1 Roquette Company Information
5.3.2 Roquette Description, Business Overview
5.3.3 Roquette Orally Disintegrating Tablet Excipient Products Offered
5.3.4 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Roquette Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.3.6 Roquette Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.3.7 Roquette Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.3.8 Roquette Recent Developments
5.4 ABF Ingredients
5.4.1 ABF Ingredients Company Information
5.4.2 ABF Ingredients Description, Business Overview
5.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Products Offered
5.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.4.5 ABF Ingredients Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.4.6 ABF Ingredients Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.4.7 ABF Ingredients Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.4.8 ABF Ingredients Recent Developments
5.5 DFE Pharma
5.5.1 DFE Pharma Company Information
5.5.2 DFE Pharma Description, Business Overview
5.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Products Offered
5.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.5.5 DFE Pharma Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.5.6 DFE Pharma Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.5.7 DFE Pharma Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.5.8 DFE Pharma Recent Developments
5.6 Evonik
5.6.1 Evonik Company Information
5.6.2 Evonik Description, Business Overview
5.6.3 Evonik Orally Disintegrating Tablet Excipient Products Offered
5.6.4 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Evonik Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.6.6 Evonik Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.6.7 Evonik Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.6.8 Evonik Recent Developments
5.7 Merck KGaA
5.7.1 Merck KGaA Company Information
5.7.2 Merck KGaA Description, Business Overview
5.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Products Offered
5.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Merck KGaA Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.7.6 Merck KGaA Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.7.7 Merck KGaA Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.7.8 Merck KGaA Recent Developments
5.8 Ashland
5.8.1 Ashland Company Information
5.8.2 Ashland Description, Business Overview
5.8.3 Ashland Orally Disintegrating Tablet Excipient Products Offered
5.8.4 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Ashland Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.8.6 Ashland Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.8.7 Ashland Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.8.8 Ashland Recent Developments
5.9 Meggle Pharma
5.9.1 Meggle Pharma Company Information
5.9.2 Meggle Pharma Description, Business Overview
5.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Products Offered
5.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Meggle Pharma Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.9.6 Meggle Pharma Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.9.7 Meggle Pharma Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.9.8 Meggle Pharma Recent Developments
5.10 Shin-Etsu
5.10.1 Shin-Etsu Company Information
5.10.2 Shin-Etsu Description, Business Overview
5.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Products Offered
5.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Shin-Etsu Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.10.6 Shin-Etsu Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.10.7 Shin-Etsu Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.10.8 Shin-Etsu Recent Developments
5.11 Fuji Chemical Industries
5.11.1 Fuji Chemical Industries Company Information
5.11.2 Fuji Chemical Industries Description, Business Overview
5.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Products Offered
5.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.11.6 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.11.7 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.11.8 Fuji Chemical Industries Recent Developments
5.12 McePharma (Vivesa holding)
5.12.1 McePharma (Vivesa holding) Company Information
5.12.2 McePharma (Vivesa holding) Description, Business Overview
5.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Products Offered
5.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.12.5 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.12.6 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.12.7 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.12.8 McePharma (Vivesa holding) Recent Developments
5.13 Cargill Incorporated
5.13.1 Cargill Incorporated Company Information
5.13.2 Cargill Incorporated Description, Business Overview
5.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Products Offered
5.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.13.6 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.13.7 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.13.8 Cargill Incorporated Recent Developments
5.14 Daicel Corporation
5.14.1 Daicel Corporation Company Information
5.14.2 Daicel Corporation Description, Business Overview
5.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Products Offered
5.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.14.5 Daicel Corporation Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.14.6 Daicel Corporation Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.14.7 Daicel Corporation Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.14.8 Daicel Corporation Recent Developments
5.15 Anhui Sunhere Pharmaceutical
5.15.1 Anhui Sunhere Pharmaceutical Company Information
5.15.2 Anhui Sunhere Pharmaceutical Description, Business Overview
5.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Products Offered
5.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
5.15.5 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales by Product in 2024
5.15.6 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales by Application in 2024
5.15.7 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales by Geographic Area in 2024
5.15.8 Anhui Sunhere Pharmaceutical Recent Developments
6 North America
6.1 North America Orally Disintegrating Tablet Excipient Market Size YoY Growth 2020-2031
6.2 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
6.2.1 North America Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
6.2.2 North America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
6.3 North America Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
6.4 North America Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Orally Disintegrating Tablet Excipient Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Region
7.2.1 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2020-2031)
7.2.2 Asia-Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2020-2031)
7.3 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
7.4 Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
8 Europe
8.1 Europe Orally Disintegrating Tablet Excipient Market Size YoY Growth 2020-2031
8.2 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
8.2.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
8.2.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
8.3 Europe Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
8.4 Europe Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Orally Disintegrating Tablet Excipient Market Size YoY Growth 2020-2031
9.2 Latin America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
9.2.1 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
9.2.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
9.3 Latin America Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
9.4 Latin America Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Orally Disintegrating Tablet Excipient Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
10.2.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
10.2.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
10.3 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
10.4 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Orally Disintegrating Tablet Excipient Supply Chain Analysis
11.2 Orally Disintegrating Tablet Excipient Key Raw Materials and Upstream Suppliers
11.3 Orally Disintegrating Tablet Excipient Clients Analysis
11.4 Orally Disintegrating Tablet Excipient Sales Channel and Sales Model Analysis
11.4.1 Orally Disintegrating Tablet Excipient Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Orally Disintegrating Tablet Excipient Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Orally Disintegrating Tablet Excipient Distributors
12 Orally Disintegrating Tablet Excipient Market Dynamics
12.1 Orally Disintegrating Tablet Excipient Industry Trends
12.2 Orally Disintegrating Tablet Excipient Market Drivers
12.3 Orally Disintegrating Tablet Excipient Market Challenges
12.4 Orally Disintegrating Tablet Excipient Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
DFE Pharma
Fuji Chemical Industries
Merck KGaA
Ashland Inc
Meggle Pharma
Cargill Incorporated
BASF
ROQUETTE
ABF Ingredients
Evonik
Shin-Etsu
McePharma (Vivesa holding)
Daicel Corporation
Anhui Sunhere Pharmaceutical
BASF AG
JRS Pharma
List of Tables
 Table 1. Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Orally Disintegrating Tablet Excipient Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Orally Disintegrating Tablet Excipient Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Orally Disintegrating Tablet Excipient Sales by Region (2020-2025) & (K MT)
 Table 5. Global Orally Disintegrating Tablet Excipient Sales Forecast by Region (2026-2031) & (K MT)
 Table 6. Global Orally Disintegrating Tablet Excipient Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Orally Disintegrating Tablet Excipient Sales Volume by Type (2020-2025) & (K MT)
 Table 9. Global Orally Disintegrating Tablet Excipient Sales Volume by Type (2026-2031) & (K MT)
 Table 10. Global Orally Disintegrating Tablet Excipient Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Orally Disintegrating Tablet Excipient Sales Volume by Application (2020-2025) & (K MT)
 Table 13. Global Orally Disintegrating Tablet Excipient Sales Volume by Application (2026-2031) & (K MT)
 Table 14. Global Orally Disintegrating Tablet Excipient Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Orally Disintegrating Tablet Excipient Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Orally Disintegrating Tablet Excipient Sales by Manufacturer (2020-2025) & (K MT)
 Table 17. Global Orally Disintegrating Tablet Excipient Sales Share by Manufacturer (2020-2025)
 Table 18. Orally Disintegrating Tablet Excipient Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Orally Disintegrating Tablet Excipient Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Orally Disintegrating Tablet Excipient Price (2020-2025) & (USD/MT)
 Table 21. Ranking of Global Top Orally Disintegrating Tablet Excipient Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Orally Disintegrating Tablet Excipient Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2024)
 Table 24. Orally Disintegrating Tablet Excipient Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
 Table 26. Manufacturers Orally Disintegrating Tablet Excipient Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. BASF Company Information
 Table 29. BASF Description and Business Overview
 Table 30. BASF Orally Disintegrating Tablet Excipient Product
 Table 31. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 32. BASF Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 33. BASF Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 34. BASF Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 35. BASF Recent Developments
 Table 36. JRS Pharma Company Information
 Table 37. JRS Pharma Description and Business Overview
 Table 38. JRS Pharma Orally Disintegrating Tablet Excipient Product
 Table 39. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 40. JRS Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 41. JRS Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 42. JRS Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 43. JRS Pharma Recent Developments
 Table 44. Roquette Company Information
 Table 45. Roquette Description and Business Overview
 Table 46. Roquette Orally Disintegrating Tablet Excipient Product
 Table 47. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 48. Roquette Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 49. Roquette Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 50. Roquette Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 51. Roquette Recent Developments
 Table 52. ABF Ingredients Company Information
 Table 53. ABF Ingredients Description and Business Overview
 Table 54. ABF Ingredients Orally Disintegrating Tablet Excipient Product
 Table 55. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 56. ABF Ingredients Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 57. ABF Ingredients Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 58. ABF Ingredients Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 59. ABF Ingredients Recent Developments
 Table 60. DFE Pharma Company Information
 Table 61. DFE Pharma Description and Business Overview
 Table 62. DFE Pharma Orally Disintegrating Tablet Excipient Product
 Table 63. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 64. DFE Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 65. DFE Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 66. DFE Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 67. DFE Pharma Recent Developments
 Table 68. Evonik Company Information
 Table 69. Evonik Description and Business Overview
 Table 70. Evonik Orally Disintegrating Tablet Excipient Product
 Table 71. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 72. Evonik Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 73. Evonik Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 74. Evonik Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 75. Evonik Recent Developments
 Table 76. Merck KGaA Company Information
 Table 77. Merck KGaA Description and Business Overview
 Table 78. Merck KGaA Orally Disintegrating Tablet Excipient Product
 Table 79. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 80. Merck KGaA Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 81. Merck KGaA Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 82. Merck KGaA Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 83. Merck KGaA Recent Developments
 Table 84. Ashland Company Information
 Table 85. Ashland Description and Business Overview
 Table 86. Ashland Orally Disintegrating Tablet Excipient Product
 Table 87. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Ashland Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 89. Ashland Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 90. Ashland Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 91. Ashland Recent Developments
 Table 92. Meggle Pharma Company Information
 Table 93. Meggle Pharma Description and Business Overview
 Table 94. Meggle Pharma Orally Disintegrating Tablet Excipient Product
 Table 95. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 96. Meggle Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 97. Meggle Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 98. Meggle Pharma Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 99. Meggle Pharma Recent Developments
 Table 100. Shin-Etsu Company Information
 Table 101. Shin-Etsu Description and Business Overview
 Table 102. Shin-Etsu Orally Disintegrating Tablet Excipient Product
 Table 103. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 104. Shin-Etsu Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 105. Shin-Etsu Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 106. Shin-Etsu Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 107. Shin-Etsu Recent Developments
 Table 108. Fuji Chemical Industries Company Information
 Table 109. Fuji Chemical Industries Description and Business Overview
 Table 110. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product
 Table 111. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 112. Fuji Chemical Industries Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 113. Fuji Chemical Industries Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 114. Fuji Chemical Industries Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 115. Fuji Chemical Industries Recent Developments
 Table 116. McePharma (Vivesa holding) Company Information
 Table 117. McePharma (Vivesa holding) Description and Business Overview
 Table 118. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product
 Table 119. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 120. McePharma (Vivesa holding) Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 121. McePharma (Vivesa holding) Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 122. McePharma (Vivesa holding) Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 123. McePharma (Vivesa holding) Recent Developments
 Table 124. Cargill Incorporated Company Information
 Table 125. Cargill Incorporated Description and Business Overview
 Table 126. Cargill Incorporated Orally Disintegrating Tablet Excipient Product
 Table 127. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 128. Cargill Incorporated Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 129. Cargill Incorporated Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 130. Cargill Incorporated Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 131. Cargill Incorporated Recent Developments
 Table 132. Daicel Corporation Company Information
 Table 133. Daicel Corporation Description and Business Overview
 Table 134. Daicel Corporation Orally Disintegrating Tablet Excipient Product
 Table 135. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 136. Daicel Corporation Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 137. Daicel Corporation Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 138. Daicel Corporation Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 139. Daicel Corporation Recent Developments
 Table 140. Anhui Sunhere Pharmaceutical Company Information
 Table 141. Anhui Sunhere Pharmaceutical Description and Business Overview
 Table 142. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product
 Table 143. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 144. Anhui Sunhere Pharmaceutical Sales Proportion of Orally Disintegrating Tablet Excipient by Product in 2024
 Table 145. Anhui Sunhere Pharmaceutical Sales Proportion of Orally Disintegrating Tablet Excipient by Application in 2024
 Table 146. Anhui Sunhere Pharmaceutical Sales Proportion of Orally Disintegrating Tablet Excipient by Geographic Area in 2024
 Table 147. Anhui Sunhere Pharmaceutical Recent Developments
 Table 148. North America Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
 Table 149. North America Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
 Table 150. North America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 151. North America Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 152. North America Orally Disintegrating Tablet Excipient Sales by Type (2020-2025) & (K MT)
 Table 153. North America Orally Disintegrating Tablet Excipient Sales by Application (2020-2025) & (K MT)
 Table 154. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2020-2025) & (K MT)
 Table 155. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Region (2026-2031) & (K MT)
 Table 156. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2020-2025) & (US$ Million)
 Table 157. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2026-2031) & (US$ Million)
 Table 158. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Type (2020-2025) & (K MT)
 Table 159. Asia-Pacific Orally Disintegrating Tablet Excipient Sales by Application (2020-2025) & (K MT)
 Table 160. Europe Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
 Table 161. Europe Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
 Table 162. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 163. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 164. Europe Orally Disintegrating Tablet Excipient Sales by Type (2020-2025) & (K MT)
 Table 165. Europe Orally Disintegrating Tablet Excipient Sales by Application (2020-2025) & (K MT)
 Table 166. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
 Table 167. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
 Table 168. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 169. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 170. Latin America Orally Disintegrating Tablet Excipient Sales by Type (2020-2025) & (K MT)
 Table 171. Latin America Orally Disintegrating Tablet Excipient Sales by Application (2020-2025) & (K MT)
 Table 172. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
 Table 173. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
 Table 174. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
 Table 175. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
 Table 176. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2020-2025) & (K MT)
 Table 177. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2020-2025) & (K MT)
 Table 178. Orally Disintegrating Tablet Excipient Key Raw Materials, Industry Status and Trend
 Table 179. Orally Disintegrating Tablet Excipient Key Raw Materials and Upstream Suppliers
 Table 180. Orally Disintegrating Tablet Excipient Clients Status and Trend
 Table 181. Orally Disintegrating Tablet Excipient Typical Clients
 Table 182. Orally Disintegrating Tablet Excipient Distributors
 Table 183. Orally Disintegrating Tablet Excipient Market Trends
 Table 184. Orally Disintegrating Tablet Excipient Market Drivers
 Table 185. Orally Disintegrating Tablet Excipient Market Challenges
 Table 186. Orally Disintegrating Tablet Excipient Market Restraints
 Table 187. Research Programs/Design for This Report
 Table 188. Key Data Information from Secondary Sources
 Table 189. Key Data Information from Primary Sources
 Table 190. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Orally Disintegrating Tablet Excipient Product Picture
 Figure 2. Global Orally Disintegrating Tablet Excipient Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2024 & 2031
 Figure 4. Binders Product Picture
 Figure 5. Glidents Product Picture
 Figure 6. Diluents Product Picture
 Figure 7. Disintegrants Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Orally Disintegrating Tablet Excipient Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 10. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application in 2024 & 2031
 Figure 11. Anti-Psychotics Drug
 Figure 12. Anti-Epileptics Drug
 Figure 13. Others
 Figure 14. Orally Disintegrating Tablet Excipient Report Years Considered
 Figure 15. Global Orally Disintegrating Tablet Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Orally Disintegrating Tablet Excipient Market Size 2020-2031 (US$ Million)
 Figure 17. Global Orally Disintegrating Tablet Excipient Sales 2020-2031 (K MT)
 Figure 18. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Region (2020-2031)
 Figure 19. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2020-2031)
 Figure 20. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Type (2020-2031)
 Figure 21. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Type (2020-2031)
 Figure 22. Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)
 Figure 23. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Application (2020-2031)
 Figure 24. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Application (2020-2031)
 Figure 25. Orally Disintegrating Tablet Excipient Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)
 Figure 26. Binders of Orally Disintegrating Tablet Excipient Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Glidents of Orally Disintegrating Tablet Excipient Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Diluents of Orally Disintegrating Tablet Excipient Revenue Market Share by Application, 2024 VS 2031
 Figure 29. Disintegrants of Orally Disintegrating Tablet Excipient Revenue Market Share by Application, 2024 VS 2031
 Figure 30. Others of Orally Disintegrating Tablet Excipient Revenue Market Share by Application, 2024 VS 2031
 Figure 31. Global Orally Disintegrating Tablet Excipient Sales Share by Manufacturer in 2024
 Figure 32. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 33. Binders Market Sales Proportion by Manufacturer in 2024
 Figure 34. Glidents Market Sales Proportion by Manufacturer in 2024
 Figure 35. Diluents Market Sales Proportion by Manufacturer in 2024
 Figure 36. Disintegrants Market Sales Proportion by Manufacturer in 2024
 Figure 37. Others Market Sales Proportion by Manufacturer in 2024
 Figure 38. North America Orally Disintegrating Tablet Excipient Revenue 2020-2031 (US$ Million)
 Figure 39. North America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
 Figure 40. North America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2025)
 Figure 41. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue 2020-2031 (US$ Million)
 Figure 42. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Region (2020-2031)
 Figure 43. Asia-Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2020-2031)
 Figure 44. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
 Figure 45. Asia-Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2025)
 Figure 46. Europe Orally Disintegrating Tablet Excipient Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2020-2031)
 Figure 48. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2020-2031)
 Figure 49. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
 Figure 50. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2025)
 Figure 51. Latin America Orally Disintegrating Tablet Excipient Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 52. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2020-2031)
 Figure 53. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2020-2025)
 Figure 54. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
 Figure 55. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2025)
 Figure 56. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 57. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2020-2031)
 Figure 58. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2020-2031)
 Figure 59. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
 Figure 60. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2025)
 Figure 61. Orally Disintegrating Tablet Excipient Supply Chain (Upstream and Downstream Market)
 Figure 62. Global Production Market Share of Orally Disintegrating Tablet Excipient Raw Materials by Region in 2024
 Figure 63. Orally Disintegrating Tablet Excipient Distribution Channels
 Figure 64. Global Orally Disintegrating Tablet Excipient Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 65. Global Orally Disintegrating Tablet Excipient Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Orally Dissolving Tablets ODT Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Orally Disintegrating Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Orally Disintegrating Tablets Market Research Report 2024
Orally Disintegrating Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mouth dissolving Tablets Market Insights Forecast to 2030
Global Fast disintegrating Tablets Market Insights Forecast to 2030
Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024
Global Rapid dissolving Tablets Market Insights Forecast to 2030
Global Orally Disintegrating Tablet Technology Market Research Report 2024
Global Excipients for Orally Disintegrating Tablets ODT Market Research Report 2024
Global Fast dissolving Tablets Market Insights Forecast to 2030
Global Orodispersible Tablets Market Insights Forecast to 2030
Global Oral Disintegrating Strips Market Research Report 2024
Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024
Global Aripiprazole Orally Disintegrating Tablets ODT Market Research Report 2025
Global Oral Solid Dosage Medicine Market Research Report 2025
Global Orodispersible Film Market Research Report 2025
Global Orally Disintegrating Films ODFs Market Research Report 2025
Global Disintegrant Excipients Market Research Report 2024
Global Fast Melt Tablet Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions